Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether nifurtimox in combination with
cyclophosphamide and topotecan are effective in the treatment of relapsed or refractory
neuroblastoma and medulloblastoma.